Evidence map›Paper›PMID 27027540›Full record

ReviewCancer science2016

Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report.

Atsushi Goto, Hiroshi Noto, Mitsuhiko Noda, Kohjiro Ueki, Masato Kasuga, Naoko Tajima, Ken Ohashi, Ryuichi Sakai, Shoichiro Tsugane, Nobuyuki Hamajima and 3 more

Abstract readReview
In one paragraph

Review in Cancer science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Dawn of a new era of diabeto-oncology.Journal of diabetes investigation · 2020
    Article
  7. Review
  8. Unfolding link between diabetes and cancer.Journal of diabetes investigation · 2017
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Atsushi GotoTokyo Women's Medical University, Tokyo, Japan.
Hiroshi NotoSt. Luke's International Hospital, Tokyo, Japan.
Mitsuhiko NodaDepartment of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
Kohjiro UekiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Masato KasugaNational Center for Global Health and Medicine, Tokyo, Japan.
Naoko TajimaJikei University School of Medicine, Tokyo, Japan.
Ken OhashiDepartment of General Internal Medicine, Dentistry and Oncologic Emergencies, National Cancer Center Hospital, Tokyo, Japan.
Ryuichi SakaiDepartment of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan.
Shoichiro TsuganeNational Cancer Center Research Center for Cancer Prevention and Screening, Tokyo, Japan.
Nobuyuki HamajimaDepartment of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kazuo TajimaDepartment of Public Health and Occupational Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Kohzoh ImaiCenter for Antibody and Vaccine Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Hitoshi NakagamaNational Cancer Center Research Institute, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment. The Joint Committee continued its work to assess the role of glycemic control in the development of cancer in patients with diabetes. This review shows that high-quality evidence examining the association between glycemic control and cancer risk is lacking.

Indexed as

Diabetes Mellitus, Type 2HumansIncidenceJapanNeoplasmsObservational Studies as TopicRandomized Controlled Trials as TopicCancerdiabetesglucose controlHbA1cobservational studiesrandomized controlled trials

Identifiers

PMID27027540
PMCPMC4814249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.